1. Novel Peptide-Based Magnetic Nanoparticle for Mesenchymal Circulating Tumor Cells Detection
- Author
-
Weikai Zhang, Zhiyuan Hu, Jierong Dong, Zihua Wang, Fanghao Shi, Zhiguo Fang, Yuehua Wang, and Fei Jia
- Subjects
chemistry.chemical_classification ,Epithelial-Mesenchymal Transition ,Chemistry ,010401 analytical chemistry ,Mesenchymal stem cell ,Epithelial cell adhesion molecule ,Peptide ,Epithelial Cell Adhesion Molecule ,Neoplastic Cells, Circulating ,010402 general chemistry ,01 natural sciences ,0104 chemical sciences ,Analytical Chemistry ,Molecular analysis ,chemistry.chemical_compound ,Circulating tumor cell ,Cell culture ,Cell Line, Tumor ,Cancer cell ,Biomarkers, Tumor ,Cancer research ,Humans ,Epithelial–mesenchymal transition ,Magnetite Nanoparticles ,Peptides - Abstract
The monitoring of circulating tumor cells (CTCs) has recently served as a promising approach for assessing prognosis and evaluating cancer treatment. We have already developed a CTCs enrichment platform by EpCAM recognition peptide-functionalized magnetic nanoparticles (EP@MNPs). However, considering heterogeneous CTCs generated through epithelial-mesenchymal transition (EMT), mesenchymal CTCs would be missed with this method. Notably, N-cadherin, overexpressed on mesenchymal CTCs, can facilitate the migration of cancer cells. Hence, we screened a novel peptide targeting N-cadherin, NP, and developed a new CTCs isolation approach via NP@MNPs to complement EpCAM methods' deficiencies. NP@MNPs had a high capture efficiency (about 85%) of mesenchymal CTCs from spiked human blood. Subsequently, CTCs were captured and sequenced at the single-cell level via NP@MNPs and EP@MNPs, RNA profiles of which showed that epithelial and mesenchymal subgroups could be distinguished. Here, a novel CTCs isolation platform laid the foundation for mesenchymal CTCs isolation and subsequent molecular analysis.
- Published
- 2021
- Full Text
- View/download PDF